Skip to content
A new “smart IUD” being developed by femtech company Verso Biosense could provide a breakthrough in monitoring women’s reproductive health, including fertility issues and endometriosis.
The Oxfordshire-based company has created a wireless intrauterine device equipped with tiny sensors that measure oxygen levels and temperature inside the uterus over several days.
CEO Kate Rowley says the goal is to better understand the uterine environment by collecting real-time data that has previously been difficult to obtain.
“Once we can see what’s happening in real time, we can start developing more personalised and effective treatments,” she explained.
One of the earliest applications could be fertility treatment, particularly for patients experiencing repeated IVF failures. By analysing biomarkers such as oxygen levels and temperature, clinicians may be able to identify the conditions that best support embryo implantation.
Historically, research into the uterus has relied on indirect measurements due to the technical challenges of collecting live data.
Verso Biosense’s device continuously gathers information through internal sensors before transmitting it for analysis.
Over time, large datasets could reveal patterns across menstrual cycles and other physiological indicators, helping researchers understand fertility, reproductive disorders, perimenopause and menopause.
The technology could also support future research into conditions such as endometriosis, polycystic ovary syndrome (PCOS) and uterine cancers, potentially enabling more personalised treatment approaches.
Read the full story here.
